Toronto Dominion Bank’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.62M | Sell |
42,851
-5,908
| -12% | -$1.47M | 0.01% | 639 |
|
|
2025
Q4 | $11.7M | Sell |
48,759
-5,598
| -10% | -$1.43M | 0.02% | 586 |
|
|
2025
Q3 | $14.9M | Sell |
54,357
-5,186
| -9% | -$1.42M | 0.02% | 511 |
|
|
2025
Q2 | $15.4M | Buy |
59,543
+8,035
| +16% | +$1.92M | 0.03% | 454 |
|
|
2025
Q1 | $11.5M | Buy |
51,508
+159
| +0.3% | +$37.1K | 0.02% | 458 |
|
|
2024
Q4 | $11.7M | Buy |
51,349
+2,099
| +4% | +$505K | 0.02% | 486 |
|
|
2024
Q3 | $12M | Buy |
49,250
+6,476
| +15% | +$1.45M | 0.02% | 422 |
|
|
2024
Q2 | $8.19M | Sell |
42,774
-1,031
| -2% | -$209K | 0.01% | 540 |
|
|
2024
Q1 | $8.67M | Sell |
43,805
-39,860
| -48% | -$7.3M | 0.01% | 522 |
|
|
2023
Q4 | $14.4M | Buy |
83,665
+6,777
| +9% | +$1.04M | 0.02% | 460 |
|
|
2023
Q3 | $11.4M | Sell |
76,888
-2,728
| -3% | -$493K | 0.02% | 469 |
|
|
2023
Q2 | $17.4M | Buy |
79,616
+2,267
| +3% | +$505K | 0.03% | 402 |
|
|
2023
Q1 | $16.9M | Buy |
77,349
+180
| +0.2% | +$39.1K | 0.03% | 367 |
|
|
2022
Q4 | $16.1M | Buy |
77,169
+12,595
| +20% | +$2.77M | 0.02% | 388 |
|
|
2022
Q3 | $14.1M | Sell |
64,574
-10,607
| -14% | -$2.41M | 0.03% | 389 |
|
|
2022
Q2 | $15.8M | Sell |
75,181
-7,414
| -9% | -$1.58M | 0.03% | 308 |
|
|
2022
Q1 | $20M | Sell |
82,595
-3,201
| -4% | -$774K | 0.03% | 293 |
|
|
2021
Q4 | $22.3M | Buy |
85,796
+6,588
| +8% | +$1.71M | 0.03% | 318 |
|
|
2021
Q3 | $20.9M | Buy |
79,208
+15,407
| +24% | +$4.21M | 0.03% | 287 |
|
|
2021
Q2 | $15.7M | Sell |
63,801
-7,092
| -10% | -$1.49M | 0.02% | 365 |
|
|
2021
Q1 | $13.8M | Sell |
70,893
-19,590
| -22% | -$3.93M | 0.02% | 356 |
|
|
2020
Q4 | $19.2M | Buy |
90,483
+8,825
| +11% | +$1.76M | 0.04% | 290 |
|
|
2020
Q3 | $14M | Sell |
81,658
-13,319
| -14% | -$2.46M | 0.03% | 304 |
|
|
2020
Q2 | $18.2M | Sell |
94,977
-13,592
| -13% | -$2.22M | 0.05% | 270 |
|
|
2020
Q1 | $16M | Sell |
108,569
-25,373
| -19% | -$4.04M | 0.05% | 254 |
|
|
2019
Q4 | $20.8M | Buy |
133,942
+28,199
| +27% | +$4.06M | 0.03% | 299 |
|
|
2019
Q3 | $14.3M | Sell |
105,743
-97,349
| -48% | -$12.8M | 0.03% | 365 |
|
|
2019
Q2 | $12.4M | Buy |
203,092
+103,650
| +104% | +$11.5M | 0.03% | 403 |
|
|
2019
Q1 | $10.3M | Buy |
99,442
+14,322
| +17% | +$1.48M | 0.02% | 482 |
|
|
2018
Q4 | $9.69M | Sell |
85,120
-7,656
| -8% | -$820K | 0.02% | 417 |
|
|
2018
Q3 | $10.7M | Buy |
92,776
+998
| +1% | +$109K | 0.02% | 442 |
|
|
2018
Q2 | $9.5M | Buy |
91,778
+14,804
| +19% | +$1.5M | 0.02% | 476 |
|
|
2018
Q1 | $7.58M | Buy |
76,974
+15,832
| +26% | +$1.5M | 0.02% | 496 |
|
|
2017
Q4 | $5.18M | Buy |
61,142
+7,216
| +13% | +$596K | 0.02% | 522 |
|
|
2017
Q3 | $4.15M | Buy |
53,926
+52,186
| +2,999% | +$3.99M | 0.01% | 513 |
|
|
2017
Q2 | $135K | Buy |
1,740
+197
| +13% | +$14.1K | ﹤0.01% | 895 |
|
|
2017
Q1 | $111K | Buy |
1,543
+324
| +27% | +$22.4K | ﹤0.01% | 917 |
|
|
2016
Q4 | $76K | Buy |
1,219
+7
| +0.6% | +$429 | ﹤0.01% | 934 |
|
|
2016
Q3 | $79K | Buy |
1,212
+442
| +57% | +$29.4K | ﹤0.01% | 951 |
|
|
2016
Q2 | $49K | Buy |
770
+4
| +0.5% | +$236 | ﹤0.01% | 894 |
|
|
2016
Q1 | $44K | Buy |
+766
| New | +$43.4K | ﹤0.01% | 944 |
|
Other funds holding RMD
VCM
VPM
DAM
Toronto Dominion Bank's RMD Position: Q1 2026 in Review
Toronto Dominion Bank reduced its ResMed (RMD) stake by 12% in Q1 2026, selling an estimated $1.47M and leaving 42,851 shares worth $9.62M. The position accounts for 0.01% of the portfolio, ranked #639.
Toronto Dominion Bank first reported a position in RMD in Q1 2016 and has held it in 41 quarters since. The position peaked at $22.3M in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Toronto Dominion Bank held 42,851 shares of ResMed worth $9.62M as of Q1 2026.
- Toronto Dominion Bank sold 5,908 ResMed shares in Q1 2026, an estimated $1.47M.
- ResMed made up 0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #639 holding.
- Toronto Dominion Bank first reported a position in ResMed in Q1 2016 and has held it in 41 quarters since.
- Toronto Dominion Bank's ResMed position peaked at $22.3M in Q4 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.